Antonioli L, Blandizzi C, Pacher P, Haskó G (2019) The Purinergic System as a pharmacological target for the treatment of Immune-mediated inflammatory diseases. Pharmacol Rev 71:345–382. https://doi.org/10.1124/pr.117.014878
Article PubMed Central CAS PubMed Google Scholar
Apryani E, Ali U, Wang ZY, Wu HY, Mao XF, Ahmad KA, Li XY, Wang YX (2020) The spinal microglial IL-10/β-endorphin pathway accounts for cinobufagin-induced mechanical antiallodynia in bone cancer pain following activation of α7-nicotinic acetylcholine receptors. J Neuroinflamm 17:75. https://doi.org/10.1186/s12974-019-1616-z
Bekő K, Koványi B, Gölöncsér F, Horváth G, Dénes Á, Környei Z, Botz B, Helyes Z, Müller CE, Sperlágh B (2017) Contribution of platelet P2Y(12) receptors to chronic complete Freund’s adjuvant-induced inflammatory pain. J Thromb Haemostasis: JTH 15:1223–1235. https://doi.org/10.1111/jth.13684
Bi Z, Zhang W, Yan X, Biomedicine, pharmacotherapy = Biomedecine (2022) & pharmacotherapie 151:113180.https://doi.org/10.1016/j.biopha.2022.113180
Blanton H, Reddy PH, Benamar K (2023) Chronic pain in Alzheimer’s disease: endocannabinoid system. Exp Neurol. https://doi.org/10.1016/j.expneurol.2022.114287
Braatz C, Komes MP, Ravichandran KA, de Fragas MG, Griep A, Schwartz S, McManus RM, Heneka MT (2023) NLRP3-directed antisense oligonucleotides reduce microglial immunoactivities in vitro. J Neurochem. https://doi.org/10.1111/jnc.15778
Chen R, Yin C, Fang J, Liu B (2021) The NLRP3 inflammasome: an emerging therapeutic target for chronic pain. J Neuroinflamm 18. https://doi.org/10.1186/s12974-021-02131-0. :84.
Cherry JD, Olschowka JA, O’Banion MK (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11:98. https://doi.org/10.1186/1742-2094-11-98
Article PubMed Central CAS PubMed Google Scholar
Deng MY, Ahmad KA, Han QQ, Wang ZY, Shoaib RM, Li XY, Wang YX (2021) Thalidomide alleviates neuropathic pain through microglial IL-10/β-endorphin signaling pathway. Biochem Pharmacol 192:114727. https://doi.org/10.1016/j.bcp.2021.114727
Article CAS PubMed Google Scholar
Ferreira SH, Lorenzetti BB, Bristow AF, Poole S (1988) Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334:698–700. https://doi.org/10.1038/334698a0
Article CAS PubMed Google Scholar
Gao F, Xiang HC, Li HP, Jia M, Pan XL, Pan HL, Li M (2018) Electroacupuncture inhibits NLRP3 inflammasome activation through CB2 receptors in inflammatory pain. Brain Behav Immun 67:91–100. https://doi.org/10.1016/j.bbi.2017.08.004
Article CAS PubMed Google Scholar
Gu N, Yi MH, Murugan M, Xie M, Parusel S, Peng J, Eyo UB, Hunt CL, Dong H, Wu LJ (2022) Spinal microglia contribute to sustained inflammatory pain via amplifying neuronal activity. Mol Brain 15:86. https://doi.org/10.1186/s13041-022-00970-3
Article PubMed Central CAS PubMed Google Scholar
Han QQ, Yin M, Wang ZY, Liu H, Ao JP, Wang YX (2020) Cynandione A alleviates neuropathic Pain through α7-nAChR-Dependent IL-10/β-Endorphin Signaling complexes. Front Pharmacol 11:614450. https://doi.org/10.3389/fphar.2020.614450
Article CAS PubMed Google Scholar
He W, Long T, Pan Q, Zhang S, Zhang Y, Zhang D, Qin G, Chen L, Zhou J (2019) Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model. J Neuroinflamm 16:78. https://doi.org/10.1186/s12974-019-1459-7
Hu JL, Zhang WJ (2023) The role and pharmacological properties of P2Y12 receptor in cancer and cancer pain. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie 157:113927. https://doi.org/10.1016/j.biopha.2022.113927
Article CAS PubMed Google Scholar
Huang F, Zhang Y, Xu Y, Xiang W, Xie C (2019) Analgesic, anti-inflammatory and sedative/hypnotic effects of Icaritin, and its effect on chloride influx in mouse brain cortical cells. Cellular and molecular biology. France) 65:99–104(Noisy-le-Grand
Ji RR, Xu ZZ, Gao YJ (2014) Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discovery 13:533–548. https://doi.org/10.1038/nrd4334
Article CAS PubMed Google Scholar
Jia D, Sun Y, Liu G, Xue M, Huang Z, Huang C (2021) Trifluoro-icaritin alleviates mechanical hypersensitivity and improves motor coordination and balance in rats with spared nerve injury-induced neuropathic pain. Neurosci Lett 761:136125. https://doi.org/10.1016/j.neulet.2021.136125
Article CAS PubMed Google Scholar
Jia D, Liu G, Sun Y, Hu Z, Huang Z, Huang C (2023) Trifluoro-icaritin ameliorates spared nerve injury-induced neuropathic pain by inhibiting microglial activation through α7nAChR-mediated blockade of BDNF/TrkB/KCC2 signaling in the spinal cord of rats. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie 157:114001. https://doi.org/10.1016/j.biopha.2022.114001
Article CAS PubMed Google Scholar
Jiang F, Xia M, Zhang Y, Chang J, Cao J, Zhang Z, Qian Z, Yang L (2022) Cannabinoid receptor-2 attenuates neuroinflammation by promoting autophagy-mediated degradation of the NLRP3 inflammasome post spinal cord injury. Front Immunol 13:993168. https://doi.org/10.3389/fimmu.2022.993168
Article PubMed Central CAS PubMed Google Scholar
Jing F, Zhang Y, Long T, He W, Qin G, Zhang D, Chen L, Zhou J (2019) P2Y12 receptor mediates microglial activation via RhoA/ROCK pathway in the trigeminal nucleus caudalis in a mouse model of chronic migraine. J Neuroinflamm 16:217. https://doi.org/10.1186/s12974-019-1603-4
Kara H, Çağlar C, Asiltürk M, Karahan S, Uğurlu M (2021) Comparison of a manual walking platform and the CatWalk gait analysis system in a rat osteoarthritis model. Adv Clin Experimental Medicine: Official Organ Wroclaw Med Univ 30:949–956. https://doi.org/10.17219/acem/137536
Kasatkina LA, Rittchen S, Sturm EM (2021) Neuroprotective and immunomodulatory action of the Endocannabinoid System under Neuroinflammation. Int J Mol Sci 22. https://doi.org/10.3390/ijms22115431
Komorowska-Müller JA, Schmöle AC (2020) CB2 receptor in Microglia: the Guardian of Self-Control. Int J Mol Sci 22. https://doi.org/10.3390/ijms22010019
Li X et al (2019) Crystal structure of the human cannabinoid receptor CB2. Cell 176:459–467. https://doi.org/10.1016/j.cell.2018.12.011
Article PubMed Central CAS PubMed Google Scholar
Li Y, Zhang H, Yang J, Zhan M, Hu X, Liu Y, Yu L, Yan X, Liang S, Zhang R, Lu Y, Li B, Liu C, Li M (2021) P2Y12 receptor as a new target for electroacupuncture relieving comorbidity of visceral pain and depression of inflammatory bowel disease. Chin Med 16:139. https://doi.org/10.1186/s13020-021-00553-9
Article PubMed Central CAS PubMed Google Scholar
Lin J, Ren J, Zhu B, Dai Y, Gao DS, Xia S, Cheng Z, Huang Y, Yu L (2022) Dimethyl Itaconate attenuates CFA-Induced Inflammatory Pain via the NLRP3/ IL-1β signaling pathway. Front Pharmacol 13:938979. https://doi.org/10.3389/fphar.2022.938979
Article PubMed Central CAS PubMed Google Scholar
Liu C, Liu DQ, Tian YK, Mei W, Tian XB, Xu AJ, Zhou YQ (2022) The emerging role of Quercetin in the treatment of Chronic Pain. Curr Neuropharmacol 20:2346–2353. https://doi.org/10.2174/1570159x20666220812122437
Article PubMed Central CAS PubMed Google Scholar
Lopes FSR, Giardini AC, Sant’Anna MB, Kimura LF, Bufalo MC, Vigerelli H, Zambelli VO, Picolo G (2022) Crotalphine modulates Microglia M1/M2 phenotypes and induces spinal Analgesia mediated by opioid-cannabinoid systems. Int J Mol Sci 23. https://doi.org/10.3390/ijms231911571
Lu C, Shi L, Sun B, Zhang Y, Hou B, Sun Y, Ma Z, Gu X (2017) A single intrathecal or intraperitoneal injection of CB2 receptor agonist attenuates Bone Cancer Pain and induces a time-dependent modification of GRK2. Cell Mol Neurobiol 37:101–109. https://doi.org/10.1007/s10571-016-0349-0
Article CAS PubMed Google Scholar
Lu Y, Cao DL, Ma LJ, Gao YJ (2022) TRAF6 contributes to CFA-Induced spinal microglial activation and Chronic Inflammatory Pain in mice. Cell Mol Neurobiol 42:1543–1555.
Comments (0)